The prognostic value of early measures of the ventilatory ratio in the ARDS ROSE trial

By rosaguerrero • September 30, 2022

Monteiro ACC, Vangala S, Wick KD, Delucchi KL, Siegel ER, Thompson BT, Liu KD, Sapru A, Sinha P, Matthay MA; NHLBI PETAL Network. The prognostic value of early measures of the ventilatory ratio in the ARDS ROSE trial. Crit Care. 2022 Sep 29;26(1):297. doi: 10.1186/s13054-022-04179-7. PMID: 36175982.

Tags: APACHE-III, ARDS, Neuromuscular blockade, Publications, Pulmonary, Critical Care & Sleep Medicine, ROSE trial, Ventilatory ratio

Heart Has Intrinsic Ketogenic Capacity that Mediates NAD+ Therapy in HFpEF

Koay YC, McIntosh B, Ng YH, Cao Y, Wang X, Han Y, Tomita S, Bai AY, Hunter B, Misra A, Loughrey CM, Bannon PG, Lal[...]

Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States

Danpanichkul P, Pang Y, Mahendru T, Tothanarungroj P, Díaz LA, Arab JP, Jatupornpakdee P, Muthiah MD, Duangsonk K, Choi WM, Huang DQ, Kim D, Noureddin[...]

Society for Palliative Radiation Oncology: Report from the Eleventh Annual Meeting (2024)

Martin EJ, Alcorn S, Johnstone C, Robbins JR, Chang EM, Bruggeman AR, Mattes MD, Simone CB 2nd. Society for Palliative Radiation Oncology: Report from the[...]